Symptomatic Refractory Resistant Carcinoid Disease
1 clinical trials · Condition
◉ Watch Symptomatic Refractory Resistant Carcinoid Disease
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease (NCT00690430) | Novartis Pharmaceuticals | 2008-04-01 |
Track Symptomatic Refractory Resistant Carcinoid Disease automatically
Every clearance here is in the API, with alerts when new ones post.